Delivery Order SPE2DR25D9628-SPE2DR26FBTDM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,697.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Terbinafine 250mg tablets in a 30-count package. The delivery order, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc. competed in open procurement and secured...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order valued at $14,293.82 to DMS Pharmaceutical Group Inc. for the supply of Terbinafine 250mg tablets (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery at its Park Ridge facility. This delivery order utilizes a firm fixed-price contract structure with an ultimate completion date of...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,111.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products, including branded and generic prescription...
- On June 20, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,922.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for Terbinafine HCL 250 mg tablets in quantities of 30, with an ultimate completion date of June 23, 2025. This award utilizes a firm fixed-price contract structure with no set-aside designation applied. The delivery order falls under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,172.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30. The contract is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and was awarded on August 5, 2025, with no set-aside designation utilized. This award is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $1,407.12 to DMS Pharmaceutical Group Inc. for Terbinafine HCL 250 mg tablets (30-count) on June 14, 2025, with an ultimate completion date of June 16, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion single-award vehicle valid through November 2026. The contract does not utilize a set-aside...
- On July 24, 2025, the Defense Logistics Agency's Medical Supply Chain, on behalf of the Department of Defense, awarded a firm fixed-price delivery order valued at $3,048.76 to DMS Pharmaceutical Group Inc. for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract, with an ultimate completion date of July 25, 2025, carries no set-aside designation and specifies Park Ridge, Illinois as the place of performance. DMS Pharmaceutical Group Inc., a woman-owned small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,055.53 for 30 tablets of Terbinafine 250mg by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025. This delivery order carries no set-aside designation and represents a single transaction under the company's larger Indefinite Delivery Contract with DLA, which is valued at approximately $500 million and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,022.44 for Terbinafine 250mg in a 30-count supply. This award was issued by the Medical Supply Chain division of the Department of Defense on July 14, 2025, with an ultimate completion date of the same day. The contract carries no set-aside designation, indicating the award was made through open competition. This delivery...
- This is a firm fixed-price delivery order for terbinafine hydrochloride 250 mg tablets, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $1,348.49 and a period of performance through July 14, 2025. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that specializes in supplying a range of medical products, including branded and generic prescription...
- SPE2DR25D9628Indefinite Delivery Contract
- SPE2DR25D9628-SPE2DR26FBTDMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,450.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Terbinafine 250mg tablets (30-count). The delivery order, issued on November 18, 2025, with an ultimate completion date of December 16, 2025, carries firm fixed-price terms and is not subject to any small business set-aside designation. DMS Pharmaceutical Group Inc. was selected based on its competitive capability in unrestricted federal procurement, demonstrating the company's ability to compete effectively against other qualified vendors for pharmaceutical supplies supporting Department of Defense healthcare operations. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025. The parent IDC carries a ceiling value of $499.9 billion and extends through December 31, 2036, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy. The Terbinafine delivery order exemplifies the type of routine pharmaceutical support authorized under the IDC framework, enabling DLA to meet recurring medical supply requirements for military healthcare facilities worldwide through established vendor relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/18/25 |